Affiliation:
1. Blood Donation and Apheresis Unit Transfusion Center of the Valencian Community Alicante Spain
2. Head of Service of Hematology and Hemotherapy Transfusion Center of the Valencian Community Alicante Spain
3. Clinical Medicine Department Miguel Hernández University of Elche Elche Spain
4. Head of Service of Processing Laboratory Transfusion Center of the Valencian Community Valencia Spain
5. Transfusion Center of the Valencian Community Valencia Spain
6. Internal Medicine Department Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research Alicante Spain
Abstract
AbstractObjectiveArboviruses are emerging as a relevant threat to transfusion safety. Pathogen inactivation methods (PIMs) may reduce the risk of transmission through transfusion, as long as they meet minimum standards for effectiveness. This study aims to assess the log reduction of viral load achieved with different PIMs, according to the blood product they are used on and the arbovirus targeted.MethodsSystematic literature review and meta‐analysis. Searches were conducted in MEDLINE and Embase. The study protocol was registered in PROSPERO CRD42022312061. We selected records reporting the log reduction of viral load achieved with the main PIMs (amotosalen + UVA light [INTERCEPT], riboflavin + UV light [Mirasol], methylene blue + visible light/UVC light [THERAFLEX], solvent detergent, amustaline [INTERCEPT] and PEN110 [Inactine]), applied to any blood product (plasma, platelets, red blood cells or whole blood) and for any arbovirus. The log reduction of viral loads was assessed by obtaining the mean log reduction factor (LRF). We compared and classified the LRF of different techniques using statistical methods.ResultsWe included 59 publications reporting LRF results in 17 arboviruses. For 13 arboviruses, including Chikungunya virus, Dengue virus, West Nile virus and Zika virus, at least one of the methods achieves adequate or optimal log reduction of viral load−mean LRF ≥4. The LRF achieved with riboflavin + UV light is inferior to the rest of the techniques, both overall and specifically for plasma, platelets preserved in platelet additive solution (PAS)/plasma, and red blood cells/whole blood. The LRF achieved using Mirasol is also lower for inactivating Chikungunya virus, Dengue virus and Zika virus. For West Nile virus, we found no significant differences. In plasma, the method that achieves the highest LRF is solvent/detergent; in platelets, THERAFLEX and INTERCEPT; and in red blood cells/whole blood, PEN110 (Inactine).ConclusionNot all PIMs achieve the same LRF, nor is this equivalent between the different arboviruses or blood products. Overall, the LRFs achieved using riboflavin + UV light (Mirasol) are inferior to those achieved with the rest of the PIMs. Regarding the others, LRFs vary by arbovirus and blood product. In light of the threat of different arboviruses, blood establishments should have already validated PIMs and be logistically prepared to implement these techniques quickly.
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Parasitology
Reference29 articles.
1. Pathogen inactivation
2. CallénL.Inactivación de patógenos en componentes sanguíneos. XXI Congreso Nacional de la SETS. Simposio S10. Accessed 10 February 2022.http://www.sets.es/index.php/cursos/biblioteca-virtual/congresos-1/congreso-2010/210-ponencias-12-de-junio/file.
3. Pérez CarrilloJA.Tecnologías de reducción de patógenos: una alternativa en la seguridad transfusional. Grupo Cooperativo Iberoamericano de Medicina Transfusional (online). Accessed 10 February 2022.https://gciamt.org/wp-content/uploads/2020/05/PRT-GCIAMT-Jose%CC%81-Arnulfo-Pe%CC%81rez-Feb-2020-1.pdf.
4. PérezAI.Inactivación de hematíes. XXI Congreso Nacional de la SETS. Simposio S10‐3 (online) Accessed 10 February 2022.http://www.sets.es/index.php/cursos/biblioteca-virtual/congresos-1/congreso-2010/210-ponencias-12-de-junio/file.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献